Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03319849
Brief Title: A Study to Determine the Safety and Efficacy of Renexus® in Macular Telangiectasia Type 2

First Submitted : October 3, 2017
First Submitted that Met QC Criteria : October 19, 2017
First Posted : October 24, 2017

Last Update Submitted that Met QC Criteria : January 8, 2020
Last Update Posted : January 13, 2020 (Estimate)